Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT |
48 people with persistent H pylori infection after treatment with a triple regimen |
Adverse effects
84% with quadruple regimen 82% with triple regimen Absolute numbers not reported |
P = 0.85 |
Not significant | |
RCT |
84 people with persistent H pylori infection after treatment with a metronidazole-based triple regimen |
Mild or moderate adverse effects
45% with quadruple regimen 66% with triple regimen Absolute numbers not reported |